Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1234 |
| Name of the vaccine | CDIFF Ag |
| Microbe | Bacteria |
| Disease name | Clostridium Difficile Infection |
| Name of bacteria | Clostridium difficile |
| Type of vaccine | Recombinant |
| Nucleic acid content | Linear DNA |
| Age | 18 to 70 years |
| Description of the vaccine | Vaccine based on the F2 antigen(GSK2904545A). |
| Name of the manufacturer | GlaxoSmithKline |
| Name of the manufacturing country | Belgium |
| Year of manufacture | 2022 |
| Clinical Phase status | Clinical - Phase 1 |
| Bacterial strain | Gram-positive bacillus. |
| Efficacy | NA |
| Vaccine formulation | Suspension for injection |
| Dosage | Two doses of 0.5 mL. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | Prevention of the primary C. Diff diseases and recurrences. |
| Export | NA |
| Approval | NA |
| Adjuvant | AS01B |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination (2 doses) |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT04026009 |
| Reference | https://www.gsk.com/en-gb/research-and-development/our-pipeline/ |
| Other name | NA |
| Additional Links | NA |